(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VENO-CELL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

VENO-CELL

ST13

US500000079229146

Class

5

Filing

79229146

Registration

5567863

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

36

Latest update

07/30/2026

Trademark type

Word

Nice classes

5

Filing date

01/22/2018

Registration date

09/25/2018

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/11/2025

Last transaction

07/30/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

BE

Examiner

BLANDU, FLORENTINA

Law office

M80

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Boehringer Ingelheim Veterinary Medicine Belgium, naamloze vennootschap
GLOBAL STEM CELL TECHNOLOGY, besloten vennootschap met beperkte aansprakelijkheid

Representatives

BAP IP bvba - Brantsandpatents

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Stem cells for veterinary use; surgical implants comprising living tissue and grown from stem cells; veterinary preparations for the prevention and treatment of musculoskeletal disordersallergies or metabolic diseases; vitamin preparations for the purpose of supporting stem cell physiology; dietary supplements for the purpose of supporting stem cell physiology; pharmaceutical preparationsin the form of injectable gelspowderstablets and fluids for preventing and treating musculoskeletal disordersallergies or metabolic diseases for humans and animals

Publications

History of USPTO decisions and trademark events.

36 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

07/30/2026

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

07/05/2026

XXCR

GENERIC MADRID TRANSACTION CREATED

07/05/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

12/11/2025

C71T

CANCELLED SECTION 71

04/11/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/03/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/31/2021

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/25/2020

FINV

FINAL DECISION TRANSACTION PROCESSED BY IB

02/02/2019

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

01/24/2019

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

01/11/2019

XXCR

GENERIC MADRID TRANSACTION CREATED

01/11/2019

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

12/25/2018

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/04/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

09/25/2018

GPNX

NOTIFICATION PROCESSED BY IB

07/21/2018

PUBO

PUBLISHED FOR OPPOSITION

07/10/2018

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

07/04/2018

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

07/04/2018

NPUB

NOTICE OF PUBLICATION

06/20/2018

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

06/05/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/02/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/31/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/31/2018

ALIE

ASSIGNED TO LIE

05/31/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/25/2018

RFNT

REFUSAL PROCESSED BY IB

05/25/2018

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

05/10/2018

RFRR

REFUSAL PROCESSED BY MPU

05/10/2018

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/08/2018

CNRT

NON-FINAL ACTION WRITTEN

05/07/2018

DOCK

ASSIGNED TO EXAMINER

05/02/2018

MAFR

APPLICATION FILING RECEIPT MAILED

03/31/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

03/27/2018

LIMI

LIMITATION FROM ORIGINAL APPLICATION ENTERED

03/23/2018

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

03/22/2018

Continuous trademark protection

Get notified about every new filing that threatens VENO-CELL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.